In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2762-2764

  Gieffers, Jens ^a   Solbach, Werner ^a   Maass, Matthias ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; OFLOXACIN; PENICILLIN G; RIFAMPICIN; ROXITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY ATHEROSCLEROSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031657466     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2762     Document Type: Article

References (19)

1. Campbell, L. A., E. R. O'Brian, A. L. Cappuccio, C. C. Kuo, S. P. Wang, D. Stewart, D. L. Ratton, P. K. Cummings, and J. T. Grayston. 1995. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172:585-588.
2. Danesh, J., R. Collins, and R. Peto. 1997. Chronic infections and coronary heart disease: is there a link? Lancet 350:430-436.
3. Grayston, J. T. 1992. Infections caused by Chlamydia pneumoniae strain TWAR. Clin. Infect. Dis. 15:757-763.
4. Gupta, S., E. W. Leatham, and D. Carrington. 1997. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 96:404-407.
5. Gurfinkel, E., G. Bozovich, and A. Daroca. 1997. Randomized trial of roxithromycin in non Q-wave coronary syndromes: ROXIS pilot study. Lancet 350:404-407.
6. Hammerschlag, M. R. 1994. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob. Agents Chemother. 38:1873-1878.
7. Jackson, L. A., L. A. Campbell, C. C. Kuo, D. I. Rodriguez, A. Lee, and J. T. Grayston. 1997. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J. Infect. Dis. 176:292-295.
8. Jones, R. B., G. L. Ridgway, S. Boulding, and K. L. Hunley. 1983. In vitro activity of rifamycin alone and in combination with other antibiotics against Chlamydia trachomatis. Rev. Infect. Dis. 5(Suppl. 3):556-561.
9. Kuo, C.-C., and J. T. Grayston. 1988. In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob. Agents Chemother. 32:257-258.
10. Kuo, C. C., J. T. Grayston, L. A. Campbell, Y. A. Goo, R. W. Wissler, and E. P. Benditt. 1995. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. Natl. Acad. Sci. USA 92:6911-6914.
11. Maass, M., C. Bartels, and P. M. Engel. 1998. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J. Am. Coll. Cardiol. 31:827-832.
12. Maass, M., and J. Gieffers. 1997. Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile. J. Infect. 35:171-176.
13. Maass, M., and J. Gieffers. 1996. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol. Infect. Dis. 6:65-70.
14. Maass, M., and D. Harig. 1995. Evaluation of culture conditions used for isolation of Chlamydia pneumoniae. Am. J. Clin. Pathol. 103:141-148.
15. Maass, M., E. Krause, P. M. Engel, and S. Krüger. 1997. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology 48:699-706.
16. Ramirez, J. A. 1996. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann. Intern. Med. 15:979-982.
17. Roblin, P. M., and M. R. Hammerschlag. 1998. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. Antimicrob. Agents Chemother. 42:194-196.
18. Saikku, P., M. Leinonen, K. Mattila, M. R. Ekman, M. S. Nieminen, P. H. Mäkelä, J. K. Huttunen, and V. Valtonen. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii:983-986.
19. Schachter, J. 1983. Rifampin in chlamydial infections. Rev. Infect. Dis. 5(Suppl. 3):562-564.